WWW.EXFILE.COM, INC. -- BOSTON SCIENTIFIC CORP. -- FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 
 
FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of Report (Date of earliest event reported):     October 30, 2007

 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)

DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
    

One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

Registrant’s telephone number, including area code:  (508) 650-8000
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
ITEM 1.01
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
 
On October 30, 2007, the Board of Directors approved an amendment to the Executive Allowance Plan to include members of the Company’s Operating Committee who are at a specified grade level in addition to Division Presidents.  The Plan, as amended, is attached as Exhibit 10.1.
 
 
 
ITEM 5.02
DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS.
 
The Company’s Executive Vice President, Secretary and General Counsel, Paul W. Sandman, announced his decision to retire from the Company effective February 29, 2008.  The Company plans to announce a successor at a later date.
 
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
Exhibit
Number
Description
   
10.1
Executive Allowance Plan.
   
 
  
 
- 2 -
 
 
SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
     
  BOSTON SCIENTIFIC CORPORATION
   
 
 		  
 		  
 
Date:       November 2, 2007 By:   /s/ Lawrence J. Knopf
 
Lawrence J. Knopf
 
Senior Vice President and Deputy General Counsel
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 3 -

INDEX TO EXHIBITS
 

 
Exhibit
Number
Description
 
   
10.1
Executive Allowance Plan.
   
 
  
   
    
 
 
 
 
 
- 4 -